Date published: 2026-5-29

1-800-457-3801

SCBT Portrait Logo
Seach Input

SLC25A23 Activators

SLC25A23 activators are specialized molecules designed to enhance the function of the SLC25A23 protein, a member of the solute carrier 25 (SLC25) family that is integral to the transport of ions and other solutes across the inner mitochondrial membrane. SLC25A23 specifically is implicated in the exchange of calcium and phosphate ions, which is crucial for various cellular processes including energy metabolism, signal transduction, and the maintenance of mitochondrial integrity and function. By increasing the activity of SLC25A23, these activators aim to promote the efficient transport of these ions, which in turn could affect the mitochondrial capacity to generate ATP and regulate intracellular calcium signaling. The activation could occur through a direct interaction with the protein, potentially leading to a conformational change that results in an increased transport rate or affinity for calcium and phosphate ions. Alternatively, activators may indirectly enhance SLC25A23 activity by upregulating its expression or by modulating the lipid environment of the mitochondrial membrane to favor the protein's optimal activity.

The pursuit of SLC25A23 activators begins with compound screening, where libraries of small molecules are assessed for their ability to increase the activity of SLC25A23. These compounds may be identified through their effects on mitochondrial calcium uptake or phosphate transport in isolated mitochondria or cellular models. Following the identification of promising activators, detailed mechanistic studies are conducted to elucidate how these molecules interact with SLC25A23. Such studies often involve a combination of biochemical assays to measure the transport activity of SLC25A23 in the presence of potential activators, as well as biophysical approaches to determine the binding affinity and kinetics of these interactions.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid may upregulate SLC25A23 by binding to nuclear receptors which initiate transcriptional activation of genes including those related to mitochondrial function.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin could stimulate SLC25A23 expression by elevating cAMP, which in turn activates protein kinase A, leading to enhanced transcription of cAMP-responsive genes.

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$71.00
$163.00
$296.00
2
(1)

Cholecalciferol might upregulate SLC25A23 by engaging with the vitamin D receptor, prompting the transcription of genes that govern energy metabolism and calcium transport.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A may stimulate the expression of SLC25A23 by inhibiting histone deacetylase, which results in a more transcriptionally active chromatin state.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By causing DNA demethylation, 5-Azacytidine can increase the expression of genes that have been silenced by methylation, which could include SLC25A23.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol has the potential to upregulate SLC25A23 expression by activating sirtuins and modifying the activity of transcription factors that govern mitochondrial biogenesis.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium may induce SLC25A23 expression through inhibition of GSK-3, leading to the activation of transcription factors involved in mitochondrial protection and biogenesis.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium butyrate could increase SLC25A23 expression by enhancing histone acetylation, thereby promoting gene transcription linked to mitochondrial function and energy metabolism.

Metformin-d6, Hydrochloride

1185166-01-1sc-218701
sc-218701A
sc-218701B
1 mg
5 mg
10 mg
$292.00
$822.00
$1540.00
1
(1)

Metformin is known to induce SLC25A23 by activating AMPK, which can shift cellular energy metabolism and stimulate the transcription of adaptive response genes.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$55.00
$125.00
13
(1)

Pioglitazone can stimulate SLC25A23 transcription by acting as a PPARγ agonist, which leads to an upregulation of genes involved in lipid and glucose metabolism.